Approval · Notice of Compliance 32425 · 2023
T-LO: Notice of Compliance 32425
Issued December 22, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32425
- Date
- December 22, 2023
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the composition of a dosage form. Update the Product Monograph to the Master Template.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| T-LO | Not yet assigned | — |
| TIMOLOL MALEATE-EX | Not yet assigned | — |
Medicinal ingredients
- TIMOLOL MALEATE 0.25 PER
- TIMOLOL MALEATE 0.5 PER